AI Summary ProAmatine (midodrine) is an oral vasoconstrictor used off label, usually short to medium term, as part of combination therapy for hepatorenal syndrome in people with advanced liver disease.
Medically reviewed.
ProAmatine (midodrine) is an oral vasoconstrictor that healthcare providers use off label as part of combination therapy for hepatorenal syndrome (HRS), which is worsening kidney function related to advanced liver disease. It helps raise blood pressure and improve blood flow to the kidneys, and it is often given together with albumin and octreotide. Treatment decisions should always be individualized and guided by a healthcare professional.
This page covers ProAmatine's role in hepatorenal syndrome care — how it works, who may be eligible, what treatment involves, benefits, side effects, and monitoring. You can also connect with a liver specialist near you for personalized guidance on whether ProAmatine fits your care plan.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
ABOUT PROAMATINE TREATMENT
ProAmatine is a brand name for midodrine, an oral medicine known as a vasoconstrictor. A vasoconstrictor tightens blood vessels, which raises blood pressure.
Healthcare providers use midodrine off label as part of combination therapy for hepatorenal syndrome (HRS). Off label means a provider prescribes a medicine for a use that is not listed in its official approval. In advanced liver disease, midodrine helps increase blood pressure and improve blood flow to the kidneys.
It is often given together with albumin infusion and octreotide (Sandostatin). Your healthcare team checks your blood pressure and kidney function regularly, often alongside other liver tests.
WHO PROAMATINE MAY BE SUITABLE FOR
Eligibility for ProAmatine depends on your diagnosis, your blood pressure, your kidney function, and the rest of your treatment plan. Healthcare providers may prescribe it for people with hepatorenal syndrome, for low blood pressure related to advanced liver disease, or when circulatory support is needed. It may be added when a provider decides that extra vasoconstriction would help, and it is often part of a combination with albumin and octreotide.
Because every patient's health profile is different, there is no one-size-fits-all answer to who should take ProAmatine. Treatment decisions are individualized and should be made by a qualified healthcare professional after a full assessment of your liver condition, kidney function, and treatment goals.
ELIGIBILITY OVERVIEW
ProAmatine may be considered for adults with the following conditions or treatment needs:
Before recommending ProAmatine, healthcare providers evaluate several factors to determine whether it is an appropriate option, including:
HOW PROAMATINE CAN HELP YOUR KIDNEYS
ProAmatine stimulates alpha-1 adrenergic receptors, which are found on blood vessels. This makes the blood vessels tighten, which raises blood pressure.
In advanced liver disease, blood pressure can drop and the kidneys may not get enough blood. By raising blood pressure, ProAmatine helps improve blood flow to the kidneys. This supports the treatment of hepatorenal syndrome.
ProAmatine is not used on its own for this purpose. Providers usually combine it with albumin infusion and octreotide (Sandostatin), and they monitor blood pressure and kidney function to track your response.
LIVER BENEFITS
ProAmatine stimulates alpha-1 adrenergic receptors, which are found on blood vessels. This makes the vessels tighten, a process called vasoconstriction. In advanced liver disease, your provider may add this extra vasoconstriction when they decide it is needed.
Advanced liver disease can lower blood pressure and weaken circulation. By raising blood pressure, ProAmatine helps give circulatory support to people who need it. Your provider adjusts the dose to your blood pressure so that it does not rise too high.
Your kidneys depend on steady blood flow. In advanced cirrhosis, that flow can drop and kidney function can be at risk. By raising blood pressure, ProAmatine may improve blood flow to the kidneys, which supports treatment of hepatorenal syndrome (HRS).
Providers usually use ProAmatine short to medium term. Treatment continues until kidney function stabilizes, a definitive therapy such as liver transplant is performed, or the medicine is no longer helping. Long-term use is uncommon and needs ongoing reassessment.
ProAmatine supports blood pressure, circulation, and kidney blood flow in advanced liver disease. It should only be started and monitored under the guidance of a qualified healthcare professional.
TREATMENT PROCESS
ProAmatine is supplied as oral tablets. Take it exactly as prescribed by your healthcare provider, and check with your pharmacist if you have any questions about your tablets.
Typical doses range from 7.5 to 12.5 mg three times daily. Your healthcare provider adjusts the dose based on your blood pressure and how you respond, and raises it carefully to avoid blood pressure that is too high.
ProAmatine is a tablet taken by mouth, not an injection or infusion. Take it during the daytime while upright. The last dose is usually given at least 4 hours before bedtime to lower the risk of high blood pressure while lying down (supine hypertension). Always use it exactly as your healthcare provider directs.
ProAmatine is usually used short to medium term for hepatorenal syndrome or circulatory failure related to advanced cirrhosis. Treatment continues until kidney function stabilizes, a definitive therapy such as liver transplant is performed, or the medicine is no longer helping. Long-term use is uncommon and needs ongoing reassessment. Do not stop taking it without first talking to your healthcare provider.
Store ProAmatine tablets at room temperature, away from moisture and heat.
Your healthcare provider will regularly monitor your blood pressure and kidney function. Attend all follow-up appointments for laboratory tests and blood pressure checks, and report any side effects or unusual symptoms.
BENEFITS AND SAFETY
ProAmatine (midodrine) may support people with hepatorenal syndrome by raising blood pressure and improving blood flow to the kidneys. It is an oral tablet, and it is often used together with albumin and octreotide. The extent of these benefits varies from person to person, depending on liver condition, kidney function, and how the body responds to therapy. ProAmatine is not a stand-alone treatment. It works as part of a broader care plan with close monitoring of blood pressure and kidney function.
As with any medication, ProAmatine may cause side effects. Your healthcare provider will monitor your blood pressure and kidney function throughout treatment and assess whether ProAmatine remains a suitable option for you.
BENEFITS
ProAmatine helps improve circulatory function. This matters most when low blood pressure comes from advanced liver disease and a person needs circulatory support.
ProAmatine comes as tablets, so it does not need an injection or infusion. You take it during the daytime while upright. Store the tablets at room temperature, away from moisture and heat.
Your healthcare provider adjusts the dose step by step, based on your blood pressure and how you respond, so your blood pressure does not rise too high. The last dose is usually given at least 4 hours before bedtime.
Providers often use ProAmatine together with albumin and octreotide as one combined plan. Follow-up visits for laboratory tests and blood pressure checks help your team decide whether the plan still fits your needs.
Taking your last dose at least 4 hours before bedtime helps lower the risk of high blood pressure while lying down. Your healthcare provider will discuss the potential benefits and risks before treatment and provide ongoing support, including blood pressure monitoring, to ensure safe use.
SUPPORTING YOUR RESULTS
Lifestyle habits are an important part of your care plan alongside ProAmatine. Following your healthcare team's guidance helps keep treatment safe and effective.
These habits can support how your body responds to treatment and help your team monitor your progress over time.
Areas that may support treatment:
common questions
ProAmatine (Midodrine) is an oral vasoconstrictor that healthcare providers use off label as part of combination therapy for hepatorenal syndrome. It tightens blood vessels, which raises blood pressure and may improve blood flow to the kidneys in people with advanced liver disease. Off label means a provider prescribes a medicine for a use not listed in its official approval. Your healthcare provider can explain why ProAmatine may or may not fit your care plan.
Your healthcare provider decides whether ProAmatine suits you, based on your diagnosis, blood pressure, kidney function, and other treatments. Providers may consider it for people with hepatorenal syndrome, low blood pressure related to advanced liver disease, or a need for circulatory support. It is often part of a combination with albumin and octreotide. Because every health profile is different, a specialist needs to assess your liver condition and treatment goals before recommending it.
ProAmatine may help, but results vary from person to person. By raising blood pressure, it may improve blood flow to the kidneys, which supports treatment of hepatorenal syndrome. How much it helps depends on your liver condition, kidney function, and how your body responds. It is not a stand-alone treatment, and providers usually combine it with albumin and octreotide. Ask your healthcare provider how your response will be tracked and what goals to expect.
Take ProAmatine tablets exactly as your healthcare provider directs, during the daytime while upright. The last dose is usually given at least 4 hours before bedtime to lower the risk of high blood pressure while lying down. Your provider sets and adjusts your dose based on your blood pressure and response, so do not change it on your own. Store the tablets at room temperature, away from moisture and heat.
Common side effects of ProAmatine include elevated blood pressure, tingling sensations, goosebumps, urinary retention, and headache. Taking your last dose at least 4 hours before bedtime helps lower the risk of high blood pressure while lying down. Your healthcare team checks your blood pressure and kidney function regularly during treatment. Report any side effects or unusual symptoms to your provider, who can decide whether ProAmatine remains a suitable option for you.
ProAmatine is usually used short to medium term. Treatment typically continues until kidney function stabilizes, a definitive therapy such as liver transplant is performed, or the medicine is no longer helping. Long-term use is uncommon and needs ongoing reassessment. Do not stop taking ProAmatine without first talking to your healthcare provider. Follow-up appointments for laboratory tests and blood pressure checks help your team decide how long treatment should continue.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
